Belkyra™ (deoxycholic acid) is a new injectable that is very effective at reducing the appearance and profile of moderate to severe fat below the chin (submental fat). It is the first injection that has obtained FDA approval for treatment of the double chin. It is not known whether the use of Belkyra™ outside this zone is safe at this point in time.
Deoxycholic acid is a naturally occurring molecule that aids in the digestion and absorption of dietary fat. When injected into the fat underneath the chin, Belkyra™ causes the destruction of fat cells. Once destroyed, the cells can no longer store or accumulate fat.
Belkyra™ has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with Belkyra™.
The safety profile of Belkyra™ is well characterized. The most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness around the treatment area. These can last anywhere from a few days to a few weeks.
The majority of patients will experience visible results in 2 to 4 treatment sessions. During these sessions, Dr. Munk will administer Belkyra™ into the fat under your chin using multiple injections. Up to 6 treatment sessions may be administered spaced no less than one month apart.
When injected into the fat under your chin, Belkyra™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment with Belkyra™ is not expected. Results are thought to be long lasting.